Gerresheimer AG (ETR:GXI)
Germany · Delayed Price · Currency is EUR 19.89
+0.86 (4.52%)
At close: Feb 13, 2026
Gerresheimer AG Market Cap
Gerresheimer AG has a market cap or net worth of €687 million as of February 13, 2026. Its market cap has decreased by -70.02% in one year.
Market Cap
687.00M
Enterprise Value
2.88B
Revenue
2.25B
Ranking
n/a
PE Ratio
29.42
Stock Price
€19.89
Market Cap Chart
Since June 11, 2007, Gerresheimer AG's market cap has decreased from 1.20B to 687.00M, a decrease of -42.95%. That is a compound annual growth rate of -2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 687.00M | -27.88% |
| Dec 30, 2025 | 952.61M | -61.15% |
| Dec 30, 2024 | 2.45B | -24.75% |
| Dec 29, 2023 | 3.26B | 65.26% |
| Dec 30, 2022 | 1.97B | -25.86% |
| Dec 30, 2021 | 2.66B | -3.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.56B |
| Siemens Healthineers AG | 45.39B |
| Bayer Aktiengesellschaft | 45.05B |
| Fresenius SE & Co. KGaA | 28.53B |
| Redcare Pharmacy NV | 1.40B |
| Evotec SE | 1.10B |
| Eckert & Ziegler SE | 936.11M |
| RHÖN-KLINIKUM Aktiengesellschaft | 870.20M |